TTAB Oppositions 91252778

USPTO Oppositions proceeding 91252778, filed 2019-12-06. Status: Terminated.

Proceeding Facts

Proceeding Number	91252778
Type	Oppositions
Status	Terminated
Filing Date	2019-12-06
Last Activity	2021-03-29
Days Active	2353

Parties

Imvax, Inc. — Defendant
Enesi Pharma Limited — Plaintiff

Plaintiff Marks

IMPLAVAX — Enesi Pharma Limited

Defendant Marks

IMVAX — Imvax, Inc.

Recent Documents

2021-03-29: TERMINATED — Status
2021-03-29: BD DECISION: OPP DISMISSED W/ PREJ — Decisions
2021-03-16: MOT TO AMEND APPLICATION — Motions
2021-02-23: RESPONSE DUE 30 DAYS (DUE DATE) — Scheduling
2020-11-13: MOT TO AMEND APPLICATION — Motions
2020-10-12: D CHANGE OF CORRESP ADDRESS — Parties
2020-10-09: RESPONSE DUE — Scheduling
2020-09-18: EXTENSION OF TIME GRANTED — Extensions
2020-09-18: P MOT FOR EXT W/ CONSENT — Motions
2020-07-29: SUSPENDED — Status
2020-07-27: P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2020-06-30: ANSWER TO COUNTERCLAIM — Pleadings
2020-06-05: CORRECTION TO BD ORDER — Administrative
2020-06-04: TRIAL DATES RESET — Scheduling
2020-04-20: ANSWER AND COUNTERCLAIM ( FEE) — Fees
2020-03-16: P OPP/RESP TO MOTION — Motions
2020-03-13: D MOT FOR EXT W/O CONSENT — Motions
2020-01-17: EXTENSION OF TIME GRANTED — Extensions
2020-01-17: D MOT FOR EXT W/ CONSENT — Motions
2019-12-09: INSTITUTED — Status
2019-12-09: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
2019-12-06: FILED AND FEE — Fees

Related